Loading clinical trials...
Loading clinical trials...
Phase II Trial of Bevacizumab in Combination With Sorafenib in Recurrent Glioblastoma Multiforme
Conditions
Interventions
bevacizumab
sorafenib tosylate
Locations
204
United States
Mayo Clinic Scottsdale
Scottsdale, Arizona, United States
Cancer Care Associates
Fresno, California, United States
Front Range Cancer Specialists
Fort Collins, Colorado, United States
Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center
Hartford, Connecticut, United States
Baptist Cancer Institute - Jacksonville
Jacksonville, Florida, United States
Mayo Clinic - Jacksonville
Jacksonville, Florida, United States
Start Date
September 1, 2008
Primary Completion Date
October 1, 2010
Completion Date
February 19, 2014
Last Updated
May 8, 2018
NCT00602667
NCT00978458
NCT00683319
NCT07416188
NCT00897286
NCT06742593
Lead Sponsor
Alliance for Clinical Trials in Oncology
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions